sorafenib has been researched along with vitamin k semiquinone radical in 4 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (vitamin k semiquinone radical) | Trials (vitamin k semiquinone radical) | Recent Studies (post-2010) (vitamin k semiquinone radical) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 12,827 | 491 | 3,703 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Carr, BI; Hyslop, T; Wang, M; Wang, Z; Wei, G | 1 |
| Choi, YI; Ha, TY; Hong, HN; Hwang, S; Kim, N; Ryoo, BY; Song, GW; Tak, E; Won, YJ; Yoon, SY | 1 |
| Haruna, Y; Kawamoto, S; Yakushijin, T | 1 |
1 trial(s) available for sorafenib and vitamin k semiquinone radical
| Article | Year |
|---|---|
Efficacy and safety of sorafenib plus vitamin K treatment for hepatocellular carcinoma: A phase II, randomized study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female; Follow-Up Studies; Humans; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Prognosis; Sorafenib; Survival Rate; Vitamin K | 2021 |
3 other study(ies) available for sorafenib and vitamin k semiquinone radical
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Vitamin K enhancement of sorafenib-mediated HCC cell growth inhibition in vitro and in vivo.
Topics: Animals; Antifibrinolytic Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzenesulfonates; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Humans; In Vitro Techniques; Liver Neoplasms; Mitogen-Activated Protein Kinase Kinases; Niacinamide; Phenylurea Compounds; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Pyridines; raf Kinases; Rats; Sorafenib; Vitamin K | 2010 |
Synergistic effect of sorafenib and vitamin K on suppression of hepatocellular carcinoma cell migration and metastasis.
Topics: Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Drug Synergism; Hep G2 Cells; Hepatocyte Growth Factor; Humans; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Sorafenib; Vitamin K | 2015 |